Total Payments
$596,044
2024 Payments
$52,077
Companies
24
Transactions
608
Medicare Patients
2,302
Medicare Billing
$654,962
Payment Breakdown by Category
Consulting$257,724 (43.2%)
Other$251,893 (42.3%)
Research$37,220 (6.2%)
Travel$31,057 (5.2%)
Food & Beverage$17,050 (2.9%)
Education$1,098 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $257,724 | 92 | 43.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $246,743 | 58 | 41.4% |
| Unspecified | $37,220 | 31 | 6.2% |
| Travel and Lodging | $31,057 | 120 | 5.2% |
| Food and Beverage | $17,050 | 280 | 2.9% |
| Honoraria | $5,150 | 3 | 0.9% |
| Education | $1,098 | 24 | 0.2% |
Payments by Type
General
$558,823
577 transactions
Research
$37,220
31 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $358,246 | 286 | $0 (2024) |
| Allergan, Inc. | $109,062 | 145 | $0 (2022) |
| Biofrontera Inc. | $49,108 | 33 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $27,337 | 31 | $0 (2019) |
| MERZ NORTH AMERICA, INC. | $24,721 | 43 | $0 (2024) |
| Solta Medical, a division of Bausch Health US, LLC | $10,361 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $4,749 | 3 | $0 (2022) |
| Almirall LLC | $4,119 | 4 | $0 (2024) |
| STRATA Skin Sciences, Inc. | $2,627 | 5 | $0 (2023) |
| Sensus Healthcare, Inc. | $2,000 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52,077 | 54 | Galderma Laboratories, L.P. ($32,693) |
| 2023 | $30,722 | 27 | Galderma Laboratories, L.P. ($15,121) |
| 2022 | $94,228 | 98 | Galderma Laboratories, L.P. ($48,661) |
| 2021 | $69,543 | 60 | Galderma Laboratories, L.P. ($49,940) |
| 2020 | $82,035 | 58 | Galderma Laboratories, L.P. ($41,185) |
| 2019 | $79,149 | 111 | Galderma Laboratories, L.P. ($24,270) |
| 2018 | $110,909 | 126 | Galderma Laboratories, L.P. ($93,978) |
| 2017 | $77,381 | 74 | Galderma Laboratories, L.P. ($52,397) |
All Payment Transactions
608 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Almirall LLC | Klisyri (Drug) | Honoraria | Cash or cash equivalent | $2,700.00 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $38.66 | General |
| Category: Dermatology | ||||||
| 11/27/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Consulting Fee | Cash or cash equivalent | $6,960.00 | General |
| 11/08/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $1,371.20 | Research |
| Study: 43BBJ1911 | ||||||
| 11/08/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $1,368.80 | Research |
| Study: 43BBJ1911 | ||||||
| 10/29/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Consulting Fee | Cash or cash equivalent | $5,072.10 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.90 | General |
| 10/16/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Food and Beverage | In-kind items and services | $96.62 | General |
| 10/16/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Food and Beverage | In-kind items and services | $31.87 | General |
| 10/16/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Food and Beverage | In-kind items and services | $11.98 | General |
| 10/16/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Food and Beverage | In-kind items and services | $8.20 | General |
| 10/15/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Travel and Lodging | In-kind items and services | $590.32 | General |
| 10/15/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Food and Beverage | In-kind items and services | $19.02 | General |
| 09/30/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $96.44 | General |
| 09/25/2024 | Solta Medical, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $32.56 | General |
| 09/13/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $2,340.00 | Research |
| Study: 43BBJ1911 | ||||||
| 09/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Dermatology | ||||||
| 08/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/16/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $1,560.00 | Research |
| Study: 43BBJ1911 | ||||||
| 08/08/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $131.39 | General |
| 07/22/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $31.25 | General |
| Category: DERMATOLOGY | ||||||
| 07/12/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $2,340.00 | Research |
| Study: 43BBJ1911 | ||||||
| 07/09/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,000.00 | General |
| 06/21/2024 | Galderma Laboratories, L.P. | — | — | Cash or cash equivalent | $2,340.00 | Research |
| Study: 43BBJ1911 | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| 43BBJ1911 | Galderma Laboratories, L.P. | $14,440 | 7 |
| Not Specific to one study | Endo Pharmaceuticals Inc. | $12,667 | 4 |
| EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy Commonly Known as Cellulite | Endo Pharmaceuticals Inc. | $3,720 | 1 |
| A randomized, double blind, vehicle-co ntrolled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA (Ameluz) and BF-RhodoLED in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT). | Biofrontera Inc. | $3,682 | 6 |
| EVALUATION OF EFFECTIVENESS AND SAFETY OF RADIESSE (+) FOR THE IMPROVEMENT OF JAWLINE VOLUME AND CONTOUR | MERZ NORTH AMERICA, INC. | $1,710 | 8 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of EN3835 In The Treatment Of Edematous Fibrosclerotic Panniculopathy Cellulite | Endo Pharmaceuticals Inc. | $1,001 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 469 | 699 | $378,517 | $126,392 |
| 2022 | 13 | 599 | 865 | $505,905 | $171,007 |
| 2021 | 11 | 611 | 905 | $535,166 | $180,720 |
| 2020 | 11 | 623 | 894 | $404,381 | $176,843 |
Total Patients
2,302
Total Services
3,363
Medicare Billing
$654,962
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 115 | 124 | $174,912 | $55,469 | 31.7% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 47 | 61 | $52,264 | $21,096 | 40.4% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 16 | 17 | $35,106 | $14,083 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 190 | $35,061 | $12,601 | 35.9% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 14 | 14 | $22,007 | $8,222 | 37.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 41 | 41 | $39,976 | $8,090 | 20.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 25 | 32 | $6,757 | $2,563 | 37.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 42 | $4,883 | $1,821 | 37.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 25 | 40 | $5,602 | $1,664 | 29.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 18 | 138 | $1,948 | $781.73 | 40.1% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 135 | 157 | $221,138 | $69,208 | 31.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 70 | 88 | $75,754 | $30,437 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 158 | 209 | $38,876 | $14,355 | 36.9% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2022 | 15 | 15 | $30,953 | $12,427 | 40.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 47 | 52 | $51,704 | $10,384 | 20.1% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2022 | 14 | 15 | $23,564 | $9,512 | 40.4% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2022 | 14 | 14 | $22,201 | $8,962 | 40.4% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 11 | 12 | $15,895 | $6,412 | 40.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 31 | 39 | $8,485 | $3,227 | 38.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 39 | 47 | $5,441 | $2,030 | 37.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $4,370 | $1,626 | 37.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 26 | 37 | $5,213 | $1,499 | 28.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 20 | 161 | $2,312 | $927.23 | 40.1% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2021 | 144 | 175 | $246,895 | $78,772 | 31.9% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2021 | 68 | 104 | $88,960 | $36,484 | 41.0% |
About Dr. Joel Cohen, M.D
Dr. Joel Cohen, M.D is a MOHS-Micrographic Surgery healthcare provider based in Greenwood Village, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386667871.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joel Cohen, M.D has received a total of $596,044 in payments from pharmaceutical and medical device companies, with $52,077 received in 2024. These payments were reported across 608 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($257,724).
As a Medicare-enrolled provider, Cohen has provided services to 2,302 Medicare beneficiaries, totaling 3,363 services with total Medicare billing of $654,962. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Greenwood Village, CO
- Active Since 07/25/2006
- Last Updated 03/17/2018
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1386667871
Products in Payments
- AMELUZ (Drug) $33,356
- BOTOX (Biological) $25,382
- Ameluz (Drug) $15,752
- BOTOX COSMETIC (Biological) $15,644
- THERMAGE FLX $7,718
- Xeomin (Biological) $5,177
- LIBTAYO (Biological) $4,820
- XIAFLEX (Biological) $3,720
- Klisyri (Drug) $2,739
- XTRAC (Device) $2,627
- WYNZORA (Drug) $1,500
- XEOMIN (Biological) $1,304
- AKLIEF (Drug) $261.37
- EPSOLAY (Drug) $226.94
- Otezla (Drug) $173.59
- CLODERM (Drug) $149.04
- DYSPORT (Biological) $148.78
- Erivedge (Biological) $142.55
- CIBINQO (Drug) $113.72
- EPIDUO (Drug) $100.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.